Found 24 matching trials
A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
PHASE3This study is a proof-of-concept study to demonstrate if a daily dose of a ...
Location
Investigational Site Number : 1240001
Colchicine in Moderate Symptomatic COVID-19 Patients
NAThis is a prospective, double blind, randomized, placebo controlled clinica...
Location
Dhaka Medical College Hospital
Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout
PHASE4The purpose of this study is to assess the potential for pegloticase with m...
Location
University of Alabama
A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol
PHASE1This will be a double-blind, placebo-controlled study with a 4-way crossove...
Effect of Antihistamines on Ureteral Stent-Related Symptoms
PHASE2This is a prospective, double-blind, randomized, open-label, single-center ...
Location
Columbia University Irving Medical Center/NYP
A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects
PHASE1The purpose of this study in heathy people is to investigate the safety, to...
Location
Pfizer Clinical Research Unit
Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.
PHASE3The loratadine-pseudoephedrine combination has proven to be more effective ...
Location
Lal Clínica Pesquisa E Desenvolvimento Ltda
Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers
PHASE1This Phase 1 study in healthy adult volunteers is planned to evaluate the s...
A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge
PHASE2An H3 receptor antagonist should reduce the congestion associated with alle...
Location
Pfizer Investigational Site
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
PHASE3The purpose of this study is to investigate the efficacy and safety of fexo...
Location
Aventis Pharmaceuticals Inc.